Search
Risvodetinib
go.drugbank.com/drugs/DB21602InvestigationalRisvodetinib has a monoisotopic molecular weight of 574.28 Da.
Pirtobrutinib
go.drugbank.com/drugs/DB17472ApprovedInvestigationalIts high selectivity has been associated with lower discontinuation rates due to adverse events and a lower incidence of atrial fibrillation.
Categories: P-glycoprotein inhibitors, P-glycoprotein substratesBrincidofovir
go.drugbank.com/drugs/DB12151ApprovedInvestigational[A235725,A235735] Due to its formulation as a pro-drug brincidofovir also carries a greater bioavailability than cidofovir,[A235740,A235725] allowing for oral administration rather than intravenous.
Categories: Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2B6 InhibitorsReproxalap
go.drugbank.com/drugs/DB16688Investigational[L32990] NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome.[L32990]
Enrofloxacin
go.drugbank.com/drugs/DB11404InvestigationalVet approvedDue to the identification of fluoroquinolone-resistant strains of _Campylobacter_, in September 2005, the FDA withdrew the approval of enrofloxacin for its use in water to treat flocks of poultry.
Categories: P-glycoprotein substrates, Cytochrome P-450 CYP1A2 InhibitorsMerbromin
go.drugbank.com/drugs/DB13392Investigationalis an organomercuric disodium salt compound and a fluorescein that is available in many countries, except Switzerland, France, Germany, and the United States where the drug was withdrawn from market due
Xiliertinib
go.drugbank.com/drugs/DB21453InvestigationalXiliertinib has a monoisotopic molecular weight of 442.21 Da.
Zavacorilant
go.drugbank.com/drugs/DB21509InvestigationalZavacorilant has a monoisotopic molecular weight of 555.15 Da.
Paltimatrectinib
go.drugbank.com/drugs/DB21588InvestigationalPaltimatrectinib has a monoisotopic molecular weight of 434.13 Da.